MXPA05008080A - Inhibidores peptidicos de toxinas derivadas de la ll-37. - Google Patents
Inhibidores peptidicos de toxinas derivadas de la ll-37.Info
- Publication number
- MXPA05008080A MXPA05008080A MXPA05008080A MXPA05008080A MXPA05008080A MX PA05008080 A MXPA05008080 A MX PA05008080A MX PA05008080 A MXPA05008080 A MX PA05008080A MX PA05008080 A MXPA05008080 A MX PA05008080A MX PA05008080 A MXPA05008080 A MX PA05008080A
- Authority
- MX
- Mexico
- Prior art keywords
- toxins
- peptide inhibitors
- toxins derived
- compounds
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invencion se refiere a un grupo de compuestos peptidos que tienen afinidad por toxinas y especialmente por toxinas bacterianas, tales como el lipopolisacarido o el acido lipoteicoico. Estos compuestos pueden inhibir o neutralizar las toxinas. Ademas, la presente invencion se refiere al uso de estos compuestos como agentes terapeuticos o de diagnostico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03075274 | 2003-01-28 | ||
PCT/NL2004/000060 WO2004067563A1 (en) | 2003-01-28 | 2004-01-27 | Peptide inhibitors of toxins derived from ll-37 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05008080A true MXPA05008080A (es) | 2006-02-08 |
Family
ID=32798944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05008080A MXPA05008080A (es) | 2003-01-28 | 2004-01-27 | Inhibidores peptidicos de toxinas derivadas de la ll-37. |
Country Status (20)
Country | Link |
---|---|
US (1) | US7807617B2 (es) |
EP (1) | EP1587830B1 (es) |
JP (1) | JP4471968B2 (es) |
KR (1) | KR100856819B1 (es) |
CN (1) | CN1798764B (es) |
AT (1) | ATE435870T1 (es) |
AU (1) | AU2004207118B2 (es) |
BR (1) | BRPI0407022A (es) |
CA (1) | CA2514584C (es) |
CR (1) | CR7926A (es) |
DE (1) | DE602004021901D1 (es) |
DK (1) | DK1587830T3 (es) |
ES (1) | ES2328571T3 (es) |
HK (1) | HK1088613A1 (es) |
MX (1) | MXPA05008080A (es) |
NZ (1) | NZ541657A (es) |
PT (1) | PT1587830E (es) |
RU (1) | RU2346950C2 (es) |
WO (1) | WO2004067563A1 (es) |
ZA (1) | ZA200506411B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1621205A1 (en) * | 2004-07-28 | 2006-02-01 | OctoPlus Technologies B.V. | Antimicrobial peptides derived from CAP18 |
US7465784B2 (en) * | 2006-10-26 | 2008-12-16 | Board Of Regents Of The University Of Nebraska | Antimicrobial peptides and methods of identifying the same |
US8137661B2 (en) | 2007-07-25 | 2012-03-20 | Biolex Therapeutics, Inc. | Controlled release interferon drug products and treatment of HCV infections using same |
US20130123201A1 (en) * | 2010-02-25 | 2013-05-16 | University Of Manitoba | Modulation of cytokine-induced chronic inflammatory responses |
US10723764B2 (en) | 2011-11-21 | 2020-07-28 | Board Of Regents Of The University Of Nebraska | Anti-microbial peptides and methods of use thereof |
EP2782589A4 (en) | 2011-11-21 | 2016-02-17 | Univ Nebraska | ANTIMICROBIAL PEPTIDES AND METHOD FOR THEIR USE |
RU2018128393A (ru) * | 2012-09-17 | 2019-03-14 | Мадригал Фармасьютикалз, Инк. | Способ синтеза аналогов гормонов щитовидной железы и их полиморфов |
BR112017009764A2 (pt) | 2014-11-10 | 2018-02-20 | Hoffmann La Roche | anticorpos biespecíficos e métodos de uso em oftalmologia |
RU2584089C1 (ru) * | 2015-06-15 | 2016-05-20 | Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Саратовский Государственный Медицинский Университет Имени В.И. Разумовского" Министерства Здравоохранения Российской Федерации | Способ снижения летального эффекта бактериального липополисахарида in vitro |
CN105859867A (zh) * | 2016-05-30 | 2016-08-17 | 黄石市中心医院 | 一种人源抗菌肽ll-37突变体及其应用 |
CN108892719B (zh) * | 2018-07-09 | 2021-07-30 | 珠海中科先进技术研究院有限公司 | 一种新型人源抗菌肽ll-37衍生物及其应用 |
WO2021143745A1 (zh) * | 2020-01-14 | 2021-07-22 | 中国科学院上海药物研究所 | 一种长效罗哌卡因药物组合物及其制备方法和用途 |
CN113116811A (zh) * | 2020-01-14 | 2021-07-16 | 中国科学院上海药物研究所 | 可注射长效镇痛药物组合物及其制备方法和用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103888A (en) * | 1992-07-17 | 2000-08-15 | Panorama Research, Inc. | Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity |
JP4037525B2 (ja) * | 1998-03-25 | 2008-01-23 | 生化学工業株式会社 | 新規抗菌性ペプチド |
-
2004
- 2004-01-27 RU RU2005127076/04A patent/RU2346950C2/ru not_active IP Right Cessation
- 2004-01-27 KR KR1020057013964A patent/KR100856819B1/ko not_active IP Right Cessation
- 2004-01-27 ES ES04705556T patent/ES2328571T3/es not_active Expired - Lifetime
- 2004-01-27 AU AU2004207118A patent/AU2004207118B2/en not_active Ceased
- 2004-01-27 DE DE602004021901T patent/DE602004021901D1/de not_active Expired - Lifetime
- 2004-01-27 EP EP04705556A patent/EP1587830B1/en not_active Expired - Lifetime
- 2004-01-27 PT PT04705556T patent/PT1587830E/pt unknown
- 2004-01-27 CN CN2004800085269A patent/CN1798764B/zh not_active Expired - Fee Related
- 2004-01-27 DK DK04705556T patent/DK1587830T3/da active
- 2004-01-27 NZ NZ541657A patent/NZ541657A/en not_active IP Right Cessation
- 2004-01-27 CA CA2514584A patent/CA2514584C/en not_active Expired - Fee Related
- 2004-01-27 BR BR0407022-4A patent/BRPI0407022A/pt not_active IP Right Cessation
- 2004-01-27 JP JP2006502728A patent/JP4471968B2/ja not_active Expired - Fee Related
- 2004-01-27 MX MXPA05008080A patent/MXPA05008080A/es not_active Application Discontinuation
- 2004-01-27 WO PCT/NL2004/000060 patent/WO2004067563A1/en active Application Filing
- 2004-01-27 AT AT04705556T patent/ATE435870T1/de active
- 2004-01-27 US US10/543,521 patent/US7807617B2/en not_active Expired - Fee Related
-
2005
- 2005-07-28 CR CR7926A patent/CR7926A/es not_active Application Discontinuation
- 2005-08-11 ZA ZA200506411A patent/ZA200506411B/en unknown
-
2006
- 2006-08-15 HK HK06109073.5A patent/HK1088613A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1798764A (zh) | 2006-07-05 |
NZ541657A (en) | 2009-01-31 |
DE602004021901D1 (de) | 2009-08-20 |
DK1587830T3 (da) | 2009-10-26 |
KR100856819B1 (ko) | 2008-09-05 |
EP1587830A1 (en) | 2005-10-26 |
CA2514584A1 (en) | 2004-08-12 |
PT1587830E (pt) | 2009-09-23 |
RU2005127076A (ru) | 2006-01-20 |
CR7926A (es) | 2006-02-07 |
US20060223755A1 (en) | 2006-10-05 |
JP2007528696A (ja) | 2007-10-18 |
US7807617B2 (en) | 2010-10-05 |
ES2328571T3 (es) | 2009-11-16 |
ATE435870T1 (de) | 2009-07-15 |
RU2346950C2 (ru) | 2009-02-20 |
KR20060012261A (ko) | 2006-02-07 |
EP1587830B1 (en) | 2009-07-08 |
HK1088613A1 (en) | 2006-11-10 |
AU2004207118A1 (en) | 2004-08-12 |
AU2004207118B2 (en) | 2009-12-17 |
WO2004067563A8 (en) | 2004-12-02 |
JP4471968B2 (ja) | 2010-06-02 |
CA2514584C (en) | 2012-05-29 |
ZA200506411B (en) | 2006-04-26 |
CN1798764B (zh) | 2010-05-12 |
BRPI0407022A (pt) | 2006-01-10 |
WO2004067563A1 (en) | 2004-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL232501A (en) | Peptide or polypeptide-resistant protein analogs and their uses | |
MXPA05008080A (es) | Inhibidores peptidicos de toxinas derivadas de la ll-37. | |
WO2005019258A3 (en) | Compositions and methods for the treatment of immune related diseases | |
MXPA04000173A (es) | Compuestos basados en peptidos. | |
YU37304A (sh) | Specifični agensi koji vezuju humani angiopoetin-2 | |
WO2004047728A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004039956A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2005103084A3 (en) | Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof | |
WO2004024097A8 (en) | Compositions and methods for the treatment of immune related diseases | |
MXPA05007711A (es) | Copolimero 1 para el tratamiento de enfermedades inflamatorias del intestino. | |
WO2003101401A3 (en) | Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer | |
IL195338A (en) | An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use | |
MY139124A (en) | Gyrase inhibitors and uses thereof | |
DE60028970D1 (de) | An her2 bindende peptidverbindungen | |
WO2004024068A3 (en) | Novel composition and methods for the treatment of immune related diseases | |
WO2006113681A3 (en) | Plant-derived elastin binding protein ligands and methods of using the same | |
ZA98214B (en) | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1. | |
WO2008079270A3 (en) | Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis | |
TW200724140A (en) | Hydantoin compounds | |
WO2007117680A3 (en) | Methods and compositions for treating bacterial infection | |
HK1113162A1 (en) | Treatment of fungal and/or protist infections | |
EP1423137A4 (en) | STEREO-ISOMERS OF LIPOPEPTIDE, METHODS OF PREPARATION AND USEFUL INTERMEDIATES | |
ATE400294T1 (de) | Neue antimikrobielle polypeptide und verfahren für ihre verwendung. | |
WO2004041158A3 (en) | Rifalazil compositions and therapeutic regimens | |
WO2004087073A3 (en) | Treatment of demyelinating conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: ACADEMISCH ZIEKENHUIS LEIDEN |
|
FA | Abandonment or withdrawal |